Comparisons between Thyroid Hormone Withdrawal and Recombinant Human Thyroid-stimulating Hormone Administration for Radioiodine Ablation in Patients with Intermediate-risk to High-risk Differentiated Thyroid Cancer

被引：0
|
作者：
Iizuka, Y. [1 ]
Katagiri, T. [1 ]
Ogura, K. [1 ]
Inoue, M. [1 ]
Nakamura, K. [1 ]
Mizowaki, T. [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-359
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer
    Iizuka, Yusuke
    Katagiri, Tomohiro
    Ogura, Kengo
    Inoue, Minoru
    Nakamura, Kiyonao
    Mizowaki, Takashi
    [J]. ANNALS OF NUCLEAR MEDICINE, 2020, 34 (10) : 736 - 741
  • [2] Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer
    Yusuke Iizuka
    Tomohiro Katagiri
    Kengo Ogura
    Minoru Inoue
    Kiyonao Nakamura
    Takashi Mizowaki
    [J]. Annals of Nuclear Medicine, 2020, 34 : 736 - 741
  • [3] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [4] Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer
    Park, Sohyun
    Bang, Ji-In
    Kim, Keunyoung
    Seo, Youngduk
    Chong, Ari
    Hong, Chae Moon
    Lee, Dong-Eun
    Choi, Miyoung
    Lee, Sang-Woo
    Oh, So Won
    [J]. CLINICAL NUCLEAR MEDICINE, 2024, 49 (03) : E96 - E104
  • [5] Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults
    Schumm, Max A.
    Pyo, Howard Q.
    Kim, Jiyoon
    Tseng, Chi-Hong
    Yeh, Michael W.
    Leung, Angela M.
    Chiu, Harvey K.
    [J]. CLINICAL ENDOCRINOLOGY, 2021, 95 (02) : 344 - 353
  • [6] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    Berg, G
    Lindstedt, G
    Suurküla, M
    Jansson, S
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (01) : 44 - 52
  • [7] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    G. Berg
    G. Lindstedt
    M. Suurküla
    S. Jansson
    [J]. Journal of Endocrinological Investigation, 2002, 25 : 44 - 52
  • [8] Recombinant Human Thyroid-Stimulating Hormone in Radioiodine Thyroid Remnant Ablation
    Mylonas, Chrystalleni
    Zwas, Shifra T.
    Rotenberg, Galina
    Omry, Gal
    Cohen, Ohad
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (02): : 106 - 109
  • [9] Recombinant thyroid-stimulating hormone in differentiated thyroid cancer
    Krausz, Y
    Uziely, B
    Nesher, R
    Chisin, R
    Glaser, B
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (11): : 843 - +
  • [10] Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation
    Vianello, F.
    Mazzarotto, R.
    Mian, C.
    Lora, O.
    Saladini, G.
    Servodio, O.
    Basso, M.
    Pennelli, G.
    Pelizzo, M. R.
    Sotti, G.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (03) : 162 - 168
12345